Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.

BIO CEO & Investor Digital Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Digital Conference
Jump to Day
13 Results
Available On-Demand

 

3T Biosciences is an immunotherapy company based in South San Francisco. The…

Alphageneron is a clinical stage Cell therapy company with both autologoius NK Cell therapy…
Aruvant Sciences, part of the Roivant family of companies, is a clinical-stage biopharmaceutical…
Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic…
Kodikaz is a non-viral gene therapy platform company that has the unique technology ability of…
Likarda is a cell therapy and delivery company. Likarda's foundational technology is based on…
MaxCyte is a clinical-stage global cell-based therapies and life sciences company. As the inventors…
Mogrify’s mission is to transform the development of ex vivo cell therapies and pioneer the field…
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing…
Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people…
ORYZON is a public clinical stage biopharmaceutical company and the European leader in the…
Virica pioneered a new product category of Viral Sensitizers (VSE™) that removes the barriers to…
XyloCor Therapeutics is focused on the development of novel gene therapy for unmet needs in…